Policies to enhance prescribing efficiency in europe: findings and future implications (Q35155250)

6 August 2017

Policies to enhance prescribing efficiency in europe: findings and future implications (English)

1 reference

6 August 2017

Lars L Gustafsson

25

0 references

William H Shrank

2

object named as

William Shrank

1 reference

6 August 2017

23

Bjorn Wettermark

1 reference

6 August 2017

7

Kristina Garuoliene

1 reference

6 August 2017

11

Ott Laius

1 reference

6 August 2017

16

Catherine Sermet

1 reference

6 August 2017

24

Corinne Zara

1 reference

6 August 2017

13

Rickard E Malmström

1 reference

6 August 2017

1

Brian Godman

1 reference

6 August 2017

8

Harald Herholz

1 reference

6 August 2017

10

Marija Kalaba

1 reference

6 August 2017

6

Thomas Burkhardt

1 reference

6 August 2017

9

Roberta Joppi

1 reference

6 August 2017

20

F Cankat Tulunay

1 reference

6 August 2017

22

Kamila Wendykowska

1 reference

6 August 2017

15

Vita Samaluk

1 reference

6 August 2017

19

Lesley Tilson

1 reference

6 August 2017

Morten Andersen

3

1 reference

6 August 2017

Christian Berg

4

1 reference

6 August 2017

Iain Bishop

5

1 reference

6 August 2017

Julie Lonsdale

12

1 reference

6 August 2017

Jaana E Martikainen

14

1 reference

6 August 2017

Ulrich Schwabe

17

1 reference

6 August 2017

Inês Teixeira

18

1 reference

6 August 2017

Vera Vlahović-Palčevski

21

1 reference

6 August 2017

1 January 2010

1 reference

Frontiers in Pharmacology

6 August 2017

1 reference

6 August 2017

1

1 reference

6 August 2017

141

1 reference

Getting better value from the NHS drug budget

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Generic and therapeutic substitutions in the UK: are they a good thing?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Insight into recent reforms and initiatives in Austria: implications for key stakeholders

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Forecasting drug utilization and expenditure in a metropolitan health region

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Financial incentives in the German Statutory Health Insurance: new findings, new questions.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Ongoing pharmaceutical reforms in France: implications for key stakeholder groups

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Developing competitive and sustainable Polish generic medicines market

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Patients' perceptions of generic medications

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Balancing Big Pharma's books

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

The last decade of Italian pharmaceutical policy: instability or consolidation?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in Italy.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Switching statins in Norway after new reimbursement policy: a nationwide prescription study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

How much will Herceptin really cost?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Variations and increase in use of statins across Europe: data from administrative databases

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

From best evidence to best practice: effective implementation of change in patients' care

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Influence of attitudes and behaviour of GPs on prescribing costs

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

European healthcare policies for controlling drug expenditure

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Criticism of new German chronic disease management is unfair

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Prescribing new drugs: qualitative study of influences on consultants and general practitioners

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

13 July 2018

Using clinical evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Different versions of the anatomical therapeutic chemical classification system and the defined daily dose--are drug utilisation data comparable?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Pharmacotherapeutic circles. Results of an 18-month peer-review prescribing-improvement programme for general practitioners

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Keep the Single Payer Vision

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Impact of restricted reimbursement on the use of statins in Finland: a register-based study

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Public drug expenditure in the Republic of Ireland

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Initiatives to enhance renin-angiotensin prescribing efficiency in Austria: impact and implications for other countries

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Coping with changes in the Defined Daily Dose in a longitudinal drug consumption database

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Potential savings without compromising the quality of care

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Financial incentives linked to self-assessment of prescribing patterns: a new approach for quality improvement of drug prescribing in primary care.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

The ongoing regulation of generic drugs.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Design and implementation of a point-of-care computerized system for drug therapy in Stockholm metropolitan health region--Bridging the gap between knowledge and practice.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Medication management in English National Health Service hospitals.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Healthcare policies over the last 20 years: reforms and counter-reforms

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Enhancing the rational use of new medicines across European health care systems

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153015

Influences on GPs' decision to prescribe new drugs-the importance of who says what

16 November 2018

1 reference

12 December 2020

Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists

1 reference

12 December 2020

The argument for pharmaceutical policy

1 reference

12 December 2020

Plans struggle for control of specialty pharma costs

1 reference

12 December 2020

Patients' attitudes towards and experiences of generic drug substitution in Norway

1 reference

12 December 2020

Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland

1 reference

12 December 2020

Doctors to pay for patients' medicine in Germany

1 reference

12 December 2020

Generics: what is the role of registration authorities

1 reference

12 December 2020

[Partial reimbursement of prescription charges for generic drugs reduces costs for both health insurance and patients]

1 reference

12 December 2020

Tier 4 drugs and the fraying of the social compact

1 reference

12 December 2020

Identifying existing health care services that do not provide value for money

1 reference

12 December 2020

Generic medicine pricing in Europe: current issues and future perspective

1 reference

12 December 2020

Trends in generic prescribing and dispensing in Europe

1 reference

12 December 2020

Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

1 reference

12 December 2020

Identifiers

DOI

10.3389/FPHAR.2010.00141

1 reference

6 August 2017

1 reference

6 August 2017

1 reference